These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 8433526)
1. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers]. Koike K; Fujimaki M Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526 [TBL] [Abstract][Full Text] [Related]
2. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon]. Ohsato K; Okamoto K Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885 [TBL] [Abstract][Full Text] [Related]
3. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC]. Koyama T; Aoki N Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527 [TBL] [Abstract][Full Text] [Related]
4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
5. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers. Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656 [TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C; Iijima K; Nakamura K Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [TBL] [Abstract][Full Text] [Related]
8. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation. Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924 [TBL] [Abstract][Full Text] [Related]
9. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [TBL] [Abstract][Full Text] [Related]
10. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases]. Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516 [TBL] [Abstract][Full Text] [Related]
11. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases. Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966 [TBL] [Abstract][Full Text] [Related]
12. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura. Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985 [TBL] [Abstract][Full Text] [Related]
14. [Clinical application of laboratory diagnosis: leukemia and DIC]. Deguchi K; Zhao LJ; Shirakawa S Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of hemostatic abnormality in various disease using molecular-I. Liver disease]. Shimazu C; Fukuda T; Yugeta N; Yasuda K; Wakasugi K; Tahara C; Miyajima Y; Kazama M Rinsho Byori; 1991 Mar; 39(3):295-301. PubMed ID: 1828841 [TBL] [Abstract][Full Text] [Related]
16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]
17. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators]. Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051 [No Abstract] [Full Text] [Related]
18. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100 [TBL] [Abstract][Full Text] [Related]
19. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation]. Madoiwa S Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136 [No Abstract] [Full Text] [Related]
20. [Diagnosis of predictive state of disseminated intravascular coagulation]. Yamamoto K; Saito H Nihon Rinsho; 1993 Jan; 51(1):74-8. PubMed ID: 8433531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]